Early Clinical Predictors of Treatment-Resistant Outcomes in Parkinson Disease.

被引：0
|
作者：
Kurlan, R. [1 ]
Ravina, B. [2 ]
Eberly, S. [2 ]
Oakes, D. [2 ]
Shoulson, I. [2 ]
机构：
[1] Overlook Hosp, Atlantic Neurosci Inst, Summit, NJ USA
[2] Univ Rochester, Rochester, NY USA
来源：
MOVEMENT DISORDERS | 2010年 / 25卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：VII / VIII
页数：2
相关论文
共 50 条
  • [41] Clozapine response in early treatment-resistant schizophrenia
    Joffe, G
    Rybak, J
    Burkin, M
    Burkin, D
    Appelberg, B
    Joffe, M
    Gadeke, R
    Rimon, R
    NORDIC JOURNAL OF PSYCHIATRY, 1998, 52 : 190 - 190
  • [42] Metabolomic Biomarkers in Early Parkinson's Disease.
    Umeh, C. C.
    Liao, Z.
    Dhima, K.
    Franco, D.
    Duong, K.
    Boot, B.
    Bayer, S.
    Trisini-Lipsanopoulos, A.
    Hyman, B. T.
    Dickerson, B.
    Growdon, J.
    Sudarsky, L.
    Sperling, R.
    Ivinson, A.
    Scherzer, C.
    MOVEMENT DISORDERS, 2014, 29 (10) : E7 - E7
  • [43] Rotigotine monotherapy in early Parkinson's disease.
    Morgan J.C.
    Sethi K.D.
    Current Neurology and Neuroscience Reports, 2004, 4 (4) : 273 - 274
  • [44] Positive clinical predictors of response to repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant depression
    Aydin, E. Pirdogan
    Uyar, E. Turkyilmaz
    Dalkiran, M.
    Genc, A.
    Ozer, O. A.
    Karamustalioglu, K. Oguz
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S865 - S865
  • [45] Treatment-resistant depression in schizophrenia: clinical response predictors of repetitive transcranial magnetic stimulation (rTMS)
    Maslenikov, N.
    Tsukarzi, E. E.
    Mosolov, S. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S693 - S694
  • [46] An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease
    Epstein, Charles M.
    Evatt, Marian L.
    Funk, Agnes
    Girard-Siqueira, Lhys
    Lupel, Nichole
    Slaughter, Larisa
    Athar, Saima
    Green, Joanne
    McDonald, William
    DeLong, Mahlon R.
    CLINICAL NEUROPHYSIOLOGY, 2007, 118 (10) : 2189 - 2194
  • [47] Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective
    Dold, Markus
    Leucht, Stefan
    EVIDENCE-BASED MENTAL HEALTH, 2014, 17 (02) : 33 - 37
  • [48] The issue of treatment-resistant hypertension in clinical practice
    Januszewicz, Andrzej
    Prejbisz, Aleksander
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2014, 10 (02): : 152 - 162
  • [49] Clinical Characteristics and Management of Treatment-Resistant Depression
    Conway, Charles R.
    Gebara, Marie Anne
    Walker, Marie C.
    Lessov-Schlaggar, Christina N.
    Janski, Alvin M.
    Chibnall, John T.
    Cristancho, Pilar
    Sheline, Yvette I.
    Gott, Britt M.
    Svrakic, Dragan M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (11) : 1569 - +
  • [50] Clinical presentation of treatment-resistant schizophrenia (TRS)
    Kane, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1135 - S1135
12345